In a patient with a prior peptic ulcer who requires an SSRI, how should the antidepressant be started and what gastro‑protective therapy should be used?

SSRI Use in Patients with Prior Peptic Ulcer: Management Approach

In patients with a history of peptic ulcer requiring SSRI therapy, initiate the SSRI with concurrent proton pump inhibitor (PPI) prophylaxis, as SSRIs independently increase peptic ulcer risk and this risk is amplified when combined with other ulcerogenic medications.

Understanding the Risk

SSRIs are independently associated with peptic ulcers, with current users showing a 1.5-fold increased risk of uncomplicated peptic ulcers compared to non-users 1. This association exists even in the absence of NSAIDs, suggesting a direct ulcerogenic effect beyond the known antiplatelet properties of SSRIs 1. The mechanism may involve effects on the healing process rather than solely platelet inhibition 1.

Gastro-Protective Strategy

PPI Co-Therapy is Essential

Start a PPI concurrently with the SSRI in any patient with prior peptic ulcer history. The evidence supporting this approach comes from established principles in managing high-risk patients:

• PPIs significantly reduce gastric and duodenal ulcers in high-risk populations 2
• In patients with recent complicated peptic ulcer, omeprazole was highly effective in preventing ulcer bleeding recurrence 2
• Standard-dose PPIs (not H2-receptor antagonists, which are inadequate) should be used 2
• Japanese guidelines specifically recommend PPIs or vonoprazan for patients with ulcer history 3

H. pylori Testing and Eradication

Test for H. pylori and eradicate if present, but do not rely on eradication alone for protection:

• H. pylori eradication reduces peptic ulcer incidence in patients starting ulcerogenic therapy 2
• However, for patients with previous ulcer history, H. pylori eradication alone is insufficient to prevent upper GI damage and additional PPI therapy must be added 2
• First-line eradication should use vonoprazan with antibiotics or PPIs with antibiotics 3

Critical Considerations When NSAIDs or Aspirin Are Also Needed

Additive Risk with Combined Therapy

If your patient requires both an SSRI and NSAIDs/aspirin (a common clinical scenario):

• Combined use of SSRIs with NSAIDs shows a slightly increased peptic ulcer risk (HR 1.08 for SSRIs, HR 1.15 for tricyclic antidepressants) 4
• Emerging observational data suggest SSRIs increase GI bleeding risk, which is potentiated by concomitant aspirin use 2
• The combination mandates PPI prophylaxis based on the principle that patients with prior ulcer history on aspirin or NSAIDs require gastroprotection 5, 2

Specific Algorithm for Combined Therapy

For a patient with prior peptic ulcer requiring both SSRI and NSAID/aspirin:

1. Use a COX-2 selective inhibitor (if cardiovascular risk permits) PLUS a PPI 5
2. Alternatively, use a non-selective NSAID PLUS a PPI 5
3. Always add the PPI regardless of NSAID choice in this high-risk scenario 5, 2
4. Avoid combining multiple NSAIDs (including low-dose aspirin counted as an NSAID) without gastroprotection 2

Monitoring and Compliance

Address medication adherence proactively, as poor compliance with gastroprotective therapy increases the risk of upper GI adverse events 4-6 fold 2. Discuss the importance of taking the PPI daily with the patient at initiation.

Common Pitfalls to Avoid

• Do not use H2-receptor antagonists instead of PPIs - they are inadequate for gastric ulcer prevention in high-risk patients 2
• Do not rely solely on H. pylori eradication without concurrent PPI therapy in patients with prior ulcer history 2
• Do not assume buffered or enteric-coated aspirin reduces GI risk - data do not support this 2
• Do not underestimate the independent ulcerogenic effect of SSRIs - they carry risk even without NSAIDs 1